NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives
A Addendum Notice
by NHS ENGLAND
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- 2 year
- Value
- £160M
- Sector
- HEALTH
- Published
- 28 Jan 2026
- Delivery
- 01 Apr 2026 to 31 Mar 2028
- Deadline
- 06 Feb 2026 13:00
Related Terms
Location
North East England:
Geochart for 1 buyers and 0 suppliers
1 buyer
- NHS England London
Description
Project title: NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives commencing 1st April 2026 Offer reference number: CM/TNS/25/5737 Period of framework: 1 April 2026 to 31 March 2028 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Renewal Options
Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
Award Criteria
| Price is not the only award criterion | Price is not the only award criterion and all criteria are stated in the procurement documentation |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Options are available.
- Renewals are available.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** Updated tender document set - revised Doc 3 and new doc 5c
Reference
- ocds-h6vhtk-05cf3b
- FTS 007585-2026